Cascades went into this earnings print with its stock already on a tear, up about 58% over the past three months and closing at CA$17.02 on August 7. The market priced in a turnaround story and then some. The headline today is that Cascades stayed profitable, with Q2 basic earnings per share of CA$0.21 on CA$1,219m in revenue, but momentum cooled versus Q1. The emotional gap is clear. The share price has been trading as if every quarter would look like Q1, while this report reminds investors that the profit journey in packaging and tissue is still choppy.
Is Cascades really a deep value story with a low P/E and a share price well below the stated DCF estimate, or is the interest coverage risk doing more work than it seems? Compare the implied upside and risk trade off in our valuation analysis for Cascades
Q2 2026 Earnings Summary
- Revenue (Q2 2026 vs. Q2 2025): CA$1,219m vs. CA$1,187m (up 2.7%)
- Net Income (Excl. Extra Items, Q2 2026 vs. Q2 2025): CA$21m vs. a loss of CA$3m (returned to profit)
- Basic EPS (Q2 2026 vs. Q2 2025): CA$0.21 vs. a loss of CA$0.03 per share (returned to profit)
- Adjusted EBITDA Margin, Packaging Segment (Q2 2026 vs. Q1 2026): 15.5% vs. 14.4% (up 1.1 percentage points)
Prefer clean charts instead of another wall of earnings tables and raw figures? See Cascades' full financial picture, including a clear view of its valuation, in our company report for Cascades.
Cascades bull case meets key operational tests
Bulls argue Cascades is in a real earnings upgrade cycle, driven by Bear Island ramp up, profit initiatives and better pricing power. Q2 gives some backing. Packaging adjusted EBITDA margin reached 15.5%, up from 14.4% in Q1, which lines up with management’s promised sequential gains. Bear Island ran at about 95% capacity and Greenpac hit record production, while box shipments on a comparable basis grew faster than the industry. That supports the claim of share gains and improving asset quality. Tissue is also tracking the story. Shipments increased sequentially with away from home volumes up faster than retail, consistent with the investment focus at Kingsey Falls, Granby and Pryor. Management also reports about CA$55m of cumulative savings from profitability programs since 2025, which ties directly to the narrative that internal execution, not just market pricing, is lifting earnings power.
Cascades bear case flags execution and cost pressure
The bear view is that leverage, input volatility and execution risk can cap Cascades’ upside and make the “deep value” label misleading. Q2 does not fully disarm those concerns. Leverage remains at 3.3x with only a modest CA$22m net debt reduction, while the asset sale timeline has slipped into early 2027. That keeps financing and timing risk on the table. Input costs moved against the company with recycled fiber and pulp both rising double digits quarter on quarter and logistics costs pushing up delivered prices. Tissue EBITDA fell slightly year on year despite higher sales, which shows how quickly cost inflation can squeeze margins. New U.S. tariffs could clip as much as about 5% of adjusted EBITDA run rate in a worst case before mitigation. That is a direct test of the thesis that external shocks will keep chipping away at improvements.
Access the Cascades analyst estimates for Cascades to see where the consensus models start to diverge on margins, leverage and tariffs, and to assess whether the calm share price today reflects a different potential earnings path over the coming years.Stay Ahead Of Your Next Move
If Cascades has your attention after this mixed earnings report and valuation debate, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and spot a potential entry that fits your plan. Once you are invested, use the Portfolio Command Center to cut through market noise and focus on the key updates that matter for your holdings. For a broader view, tap into the Community to compare your thinking with thousands of other investors and explore new angles on companies like Cascades. By surfacing potential catalysts and risks early, Simply Wall St aims to help you act with more confidence and stay a step ahead of the market.
Seeking Alternatives Beyond Cascades?
Fresh stock ideas can move from under the radar to the front page quickly. Use these themed lists before momentum is fully priced in and the best entries are gone. Consider getting in early.
- Explore potential breakouts in steadier businesses by scanning companies with resilient balance sheets using the curated list of solid balance sheet and fundamentals stocks (11 results).
- Focus on stronger cash generators instead of chasing hype by reviewing 68 profitable AI stocks that aren't just burning cash that already turn revenue into earnings, while attention is still catching up.
- Consider positioning for long term demand in critical materials by checking carefully selected 28 best rare earth metal stocks before more investors start moving into these supply constrained stories.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com